A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to message these accounts privately for supplier links, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and assertions of rapid UK delivery. Sellers market the drug there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, physicians and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.
Some professionals stated the demand for the experimental drug could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.
Some content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and customer laws, risking fines, prosecution or imprisonment.
Service Response and Material Elimination
Based on TikTok, the platform has removed problematic material and prohibited associated keywords and query recommendations. The organization stated it was dedicated to keeping the platform secure and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Investigations also found groups with up to nine thousand members marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, filled with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at home.
Within minutes of entering one group, a vendor shared contact information, where the majority of purchases occur. The seller provided an instruction manual and promised shipping within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.
Product Details and Pricing
Inside these groups, messages display black plastic parcels with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A representative for Telegram stated it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering materials they cannot confirm. Although the science behind retatrutide is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has previously encountered patients injured by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose patients to possibly serious medical dangers”.
